// App-Quantinova.ai

P4-01-11 : Circulating tumor cells (CTCs) detect HER2+ status and phenotypic heterogeneity in metastatic breast cancer (MBC)

Researchers

Presenter

  • Austin L

Principal Investigators

  • Mu Z

  • Avery TJaslow RPaolillo C

  • Toss A

  • Fortuna P

  • Zhong Y

  • Yang H

  • Cristofanilli M

Medical Centers

  • Univeristy of Modena and Reggio Emilia, Modena, Italy

  • Thomas Jefferson University, Philadelphia, PA

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Triple-negative breast cancer

Biomarkers

  • Circulating tumor cells

  • Collagen type IV alpha 2 chain

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Fluorescein sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved